Target intelligence / Profile preview

Broad neurotransmitter modulation via ionic mechanisms

Molecular classification
Ion channel, Ligand-gated ion channel (sometimes called ionotropic receptor), G protein–coupled receptor (GPCR, if metabotropic effects are involved)
01

Overview

"Broad neurotransmitter modulation via ionic mechanisms" refers to the general process by which neurotransmitters and neuromodulators regulate neuronal excitability and synaptic strength by modulating the activity of ion channels or ionic gradients across neuronal membranes. This can occur through direct binding to ligand-gated ion channels (ionotropic receptors, e.g., GABA-A, NMDA, AMPA, nicotinic acetylcholine receptors), or indirectly through G protein–coupled receptors and downstream signaling that alters ion channel function. A variety of physiological processes—such as action potential initiation, propagation, neurotransmitter release, and synaptic plasticity—are governed by these ionic mechanisms. The term does not define a single protein or therapeutic target but a class of molecular interactions central to nervous system function and pharmacology.

Other names
Ionic neurotransmitter modulationNeurotransmitter-gated ion channel modulationNeuromodulation via ion channels
02

Mechanism of action

Modulation of ion channel function (direct activation, inhibition, or modulation of channel gating); Alteration of ionic gradients (e.g., calcium, sodium, potassium, chloride); Metabotropic modulation altering channel activity through intracellular signaling cascades

03

Biological functions

Signal transductionSynaptic transmission regulationNeuronal excitabilityShort-term plasticitySynaptic strength and information processing
04

Disease associations

Neurodegenerative diseaseEpilepsyPsychiatric disordersPainOther CNS disorders
05

Safety considerations

Seizures (overactivation of excitatory ionic channels)Sedation, coma (overactivation of inhibitory channels)Arrhythmias (if ion channels in cardiac tissue are affected off-target)Synaptic dysregulation
06

Interacting drugs

Phenytoin

7 more in the full profile.

07

Biomarkers

Levels of neurotransmitters (glutamate, GABA, acetylcholine)Electrophysiological markers (EEG, action potential threshold)

Beyond the preview

Go deeper on Broad neurotransmitter modulation via ionic mechanisms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad neurotransmitter modulation via ionic mechanisms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call